Volume 26, Number 2 (2/2015)
Case Report <page. 58-60 >

Different Responses of Aripiprazole Combination Treatment in Antipsychotics-Induced Hyperprolactinemia: 2 Cases

Jin-Woo Cho, MD;Seung-Min Oh, MD; and Chul-Eung Kim, MD, PhD

Department of Psychiatry, Inha University School of Medicine, Inha University Hospital, Incheon, Korea

Hyperprolactinemia is a well-known neuroendocrine side effect to antipsychotic agent. Combined treatment of aripiprazole is recognized as an effective solution against hyperprolactinemia caused by antipsychotic agent. We report 2 progressive clinical cases where both are treated with combined use of aripiprazole which has a unique mechanism of action to resolve olanzapine and amisulpride-induced hyperprolactinemia.

This Article

Key words : Aripiprazole combination therapy;Hyperprolactinemia;Olanzapine;Amisulpride.